Jabil

Jabil Inc. is one of the world’s largest global contract manufacturers with deep expertise in healthcare and life sciences. The company offers end-to-end solutions spanning design engineering to commercial-scale production of medical devices and pharmaceutical products. Its recent acquisition of Pharmaceutics International Inc. (Pii) expanded its capabilities into aseptic filling, lyophilization, oral solid dose manufacturing—positioning Jabil as a major player in the CDMO market for both device-based drug delivery systems and finished pharmaceuticals. The company does not develop its own pipeline but enables rapid commercialization for clients across multiple therapeutic modalities.